Trial Profile
Clinical Trials Insight: 700043115
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2009
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Archimedes Pharma
- 26 Feb 2009 New trial record.